CALR and kidney disorder: Previous studies from our group have shown that calreticulin, an ER Ca2+ binding chaperone, is overexpressed in TECs during the progression of kidney disease in the UUO rodent model.6, 7 In the present study, we aimed to investigate the proteomic profile of calreticulin overexpressing TECs.